EUVIMEDEUVIMED entdecken
Metaanalyse

Protective Effects of ACEI/ARB on Left Ventricular Function in Anthracycline-Induced Chronic Cardiotoxicity: A Meta-Analysis of Randomized Controlled Trials

Hong Lin, Guoxi Liang, Yanxuan Wu, Liming Chen

Cardiology · 2021 · 146 (4) · 469-480

DOI: 10.1159/000512848 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Cardiology, online erschienen am 04.05.2021. Verfasst von Hong Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme Inhibitors, Anthracyclines. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Cardiotoxicity is an important side effect of anthracycline. Cardioprotective drugs for anthracycline remain inconclusive. We attempted to determine the role of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin-receptor blockers (ARB) in the prevention of anthracycline-induced cardiotoxicity. Hypothesis: Prophylactic use of ACEI/ARB reduces the clinical or subclinical cardiotoxicity of anthracycline.

Methods

Randomized controlled trials (RCTs) of ACEI/ARB in the prevention of anthracycline-induced cardiotoxicity were obtained by searching Pubmed, Embase, Web of Science, and Cochrane databases. 7 studies were finally included. A meta-analysis was performed on the 7 studies. The end points were changes in left ventricle ejection fraction (LVEF), early and late diastolic peak velocity ratio (E/A), and occurrence of hypotensive events.

Results

Prophylactic use of ACEI/ARB has potential benefits for anthracycline-induced cardiotoxicity. LVEF was better preserved in the experimental group than in the control group (weighted mean difference [WMD] −3.16%, 95% confidence interval [CI] [−5.78, −0.54], p = 0.02). Follow-up time, tumor type, drug type, and geographical region did not affect the results. There was no significant benefit of E/A in the experimental group (WMD 0.02, 95% CI [−0.06, 0.11], p = 0.58), and no increase in the incidence of hypotension (risk ratio 3.79, 95% CI [0.44, 32.89], p = 0.23).

Conclusions

We found that prophylactic use of ACEI/ARB reduced the clinical or subclinical cardiotoxicity of anthracycline, and the increase in hypotensive events was not significant. Due to the relatively small number of clinical studies and participants, more related studies are necessary to further verify our results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin-Converting Enzyme InhibitorsAnthracyclinesAngiotensin Receptor AntagonistsHumansRandomized Controlled Trials as TopicVentricular Function, Left

Stichwörter der Autor:innen

Angiotensin-converting enzyme inhibitorsAngiotensin-receptor antagonistsAnthracyclinesCardiotoxicityMeta-analysis

Substanzen

Angiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAnthracyclines

Autor:innen und Institutionen

  • Department of Oncology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Shantou University Medical College, Shantou, China.
  • Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, China.

Zitieren

APA

Lin, H., Liang, G., Wu, Y., & Chen, L. (2021). Protective Effects of ACEI/ARB on Left Ventricular Function in Anthracycline-Induced Chronic Cardiotoxicity: A Meta-Analysis of Randomized Controlled Trials. Cardiology, 146(4), 469-480. https://doi.org/10.1159/000512848

Vancouver

Lin H, Liang G, Wu Y, Chen L. Protective Effects of ACEI/ARB on Left Ventricular Function in Anthracycline-Induced Chronic Cardiotoxicity: A Meta-Analysis of Randomized Controlled Trials. Cardiology. 2021;146(4):469-480. doi:10.1159/000512848

BibTeX
@article{Lin2021,
  author = {Lin, Hong and Liang, Guoxi and Wu, Yanxuan and Chen, Liming},
  title = {Protective Effects of ACEI/ARB on Left Ventricular Function in Anthracycline-Induced Chronic Cardiotoxicity: A Meta-Analysis of Randomized Controlled Trials},
  journal = {Cardiology},
  year = {2021},
  volume = {146},
  number = {4},
  pages = {469--480},
  doi = {10.1159/000512848}
}
Kostenlos starten →